Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 6, 2024

Primary Completion Date

August 5, 2025

Study Completion Date

November 5, 2025

Conditions

Thyroid Eye DiseaseGraves Ophthalmopathy

Interventions

DRUG

Selenium

Add on Selenium (100mcg once daily) with Vitamin B Complex and Standard Treatment for Grave's Disease

Trial Locations (1)

AIIMS Bhubaneswar, Bhubaneswar

All Listed Sponsors

lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT06413043 - Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy | Biotech Hunter | Biotech Hunter